Kinesin inhibitor, Kif15-IN-2, Purity ≥98%

Cat. No.: X24-08-YM331

Kinesin inhibitor, Kif15-IN-2, Purity ≥98%

Synonym: 672926-33-9; (2S)-2-(2,4-Dioxo-1H-quinazolin-3-yl)-3-methyl-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-2-yl]butanamide

  • CAS Number: 672926-33-9
  • Compound CID: 60076305
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Kif15-IN-2 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting kinesin.
Molecular Weight
440.48
Molecular Formula
C20H20N6O4S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Kif15-IN-2 is a cytoskeletal signaling inhibitor that can be used for its potential to affect mitosis and cell division, making it a candidate for cancer treatment by impairing spindle assembly and function in tumor cells.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.